UCB (UCBJF), a global biopharmaceutical company, announced new three-year data from Phase 3 trials, and their open-label extensions, investigating ...
UCB, a global biopharmaceutical company, today announced new three-year data from Phase 3 trials, and their open-label extensions, investigating BIMZELX® (bimekizumab-bkzx) in adults with active ...
Incyte today announced new data from the Phase 3b TRuE-AD4 study evaluating the efficacy and safety of Opzelura® (ruxolitinib cream) in adults with moderate atopic dermatitis (AD) who had an ...
India Currents on MSN
Coping With Low Back Pain
Devyani’s story Devyani* is a 61-year-old first-generation American Indian who lives in Flint, Michigan. She has a sedentary ...
"You NEED to get enough sleep and do so regularly. You're setting yourself up for serious cardiac and neurological problems ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback